AssetMark Inc’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$301K Buy
14,490
+655
+5% +$14.5K ﹤0.01% 1333
2026
Q1
$322K Sell
13,835
-18,710
-57% -$583K ﹤0.01% 1240
2025
Q4
$1.44M Sell
32,545
-1,258
-4% -$70.6K ﹤0.01% 939
2025
Q3
$2.47M Buy
33,803
+1,728
+5% +$113K 0.01% 763
2025
Q2
$1.97M Buy
32,075
+10,380
+48% +$579K ﹤0.01% 772
2025
Q1
$1.26M Buy
21,695
+11,133
+105% +$703K ﹤0.01% 824
2024
Q4
$564K Buy
10,562
+10,529
+31,906% +$516K ﹤0.01% 937
2024
Q3
$1.44K Buy
33
+8
+32% +$267 ﹤0.01% 1937
2024
Q2
$699 Hold
25
﹤0.01% 1895
2024
Q1
$673 Buy
+25
New +$713 ﹤0.01% 1705
2023
Q3
Sell
-1,391
Closed -$47.3K 1756
2023
Q2
$47.3K Buy
1,391
+357
+35% +$11.9K ﹤0.01% 1093
2023
Q1
$33.5K Buy
1,034
+246
+31% +$8.16K ﹤0.01% 1117
2022
Q4
$26.4K Buy
788
+137
+21% +$4.18K ﹤0.01% 1161
2022
Q3
$20K Buy
651
+201
+45% +$7.37K ﹤0.01% 1125
2022
Q2
$16K Buy
450
+286
+174% +$11.3K ﹤0.01% 1158
2022
Q1
$9K Buy
+164
New +$8.25K ﹤0.01% 1203

Other funds holding DOCS

AssetMark Inc's DOCS Position: Q2 2026 in Review

AssetMark Inc increased its Doximity (DOCS) stake by 4.7% in Q2 2026, buying an estimated $14.5K and bringing the position to 14,490 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #1333.

AssetMark Inc first reported a position in DOCS in Q1 2022 and has held it in 16 quarters since. The position peaked at $2.47M in Q3 2025. 94 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • AssetMark Inc held 14,490 shares of Doximity worth $301K as of Q2 2026.
  • AssetMark Inc bought 655 Doximity shares in Q2 2026, an estimated $14.5K.
  • Doximity made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1333 holding.
  • AssetMark Inc first reported a position in Doximity in Q1 2022 and has held it in 16 quarters since.
  • AssetMark Inc's Doximity position peaked at $2.47M in Q3 2025.
  • 94 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.